Sponsor
Cory Anthony Booker
Senator · D-NJ
Senator · D-NJ
The resolution raises national awareness about menopause and highlights research gaps and disparities—potentially improving care and workplace support—but it is symbolic only (no funding) and could spur policy or medical responses that increase costs for employers, taxpayers, or some women.
Women (and the general public): a national designation of Oct 18 as World Menopause Day raises awareness, reduces stigma, and encourages public education and advocacy about menopause.
Women and patients with chronic conditions: the resolution highlights the need for more clinical research and development of better menopause therapies, which could drive future improvements in care and treatment options.
Black and Hispanic women (and health equity programs): identifies racial and ethnic disparities (earlier/more severe menopause) which supports targeted outreach, research, and equity-focused care efforts.
Women and patients with chronic conditions: the resolution is symbolic and does not appropriate funding or require action, so increased awareness may not translate into new services, research, or expanded care without follow-on appropriations or programs.
Small businesses and taxpayers: highlighting the economic toll could lead to policy responses (e.g., mandated accommodations or expanded programs) that increase costs for employers or require additional public spending.
Women, especially low-income individuals: framing menopause around medical risks (osteoporosis, heart disease, stroke) may increase demand for screening and treatment and thereby raise out-of-pocket medical costs for some women.
Based on analysis of 2 sections of legislative text.
Declares October 18 World Menopause Day and records findings on menopause prevalence, symptoms, workplace impacts, treatments, disparities, and research needs.
Introduced October 30, 2025 by Cory Anthony Booker · Last progress October 30, 2025
Declares October 18 as World Menopause Day and presents congressional findings about the prevalence, health effects, workplace impacts, and treatment options for menopause. The resolution highlights that by 2030 there could be about 1.2 billion menopausal or post‑menopausal women worldwide, that many U.S. women lack guidance during the menopausal transition, and that symptoms (like hot flashes) are common, often long‑lasting, and can affect work and health. The resolution notes racial and ethnic disparities in experiences of menopause, provides estimates of economic costs from lost work time, mentions available effective treatments, and calls for additional clinical research and treatment options. It is a nonbinding, awareness‑focused declaration rather than a funding or regulatory measure.